Trials / Completed
CompletedNCT02298452
Performance of a Hearing Aid Platform Including Different Styles of Hearing Aids
Structured Post Market Clinical Follow-up (PMCF) to Evaluate the Quality of a New Hearing Aid Product Generation.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 253 (actual)
- Sponsor
- Phonak AG, Switzerland · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The reason for this study is to evaluate a new hearing aid product generation replacing the one on the market. The goal is to evaluate the audiological performance, usability as well as features and functions.
Detailed description
This is a controlled, single blinded comparative study which is conducted monocentric at Phonak Headquarters in Staefa. The focus is to compare a new hearing aid product generation with the one on the market as well as with competitor devices regarding the audiological performance, usability as well as features and functions with the aid of 382 mild to profound hearing impaired subjects (18-90 yrs). The subjects, all of them native (Swiss) German speakers, individually conduct a number of laboratory standard tests and home trials (questionnaires) during nine weeks including weekly appointments of 2 hours.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hearing aid. | The hearing aid will be fitted to the individual hearing loss of the subject. |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2015-08-01
- Completion
- 2015-09-01
- First posted
- 2014-11-24
- Last updated
- 2016-05-03
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02298452. Inclusion in this directory is not an endorsement.